Wolf Group Capital Advisors’s Quest Diagnostics DGX Stock Holding History

Wolf Group Capital Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,347	Closed	-$243K	–	96
2015 Q2	$243K	Sell	3,347 -11,594	-78%	-$856K	0.16%	99
2015 Q1	$1.15M	Sell	14,941 -955	-6%	-$68.4K	0.79%	51
2014 Q4	$1.07M	Sell	15,896 -1,790	-10%	-$113K	0.77%	51
2014 Q3	$1.07M	Sell	17,686 -1,915	-10%	-$118K	0.8%	52
2014 Q2	$1.15M	Sell	19,601 -600	-3%	-$35.1K	0.84%	51
2014 Q1	$1.17M	Buy	20,201 +847	+4%	+$45.4K	0.9%	45
2013 Q4	$1.04M	Buy	+19,354	New	+$1.15M	0.83%	48

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Wolf Group Capital Advisors's DGX Position: Q3 2015 in Review

Wolf Group Capital Advisors sold out of Quest Diagnostics (DGX) in Q3 2015, closing a stake of 3,347 shares — an estimated $243K sold.

Wolf Group Capital Advisors first reported a position in DGX in Q4 2013 and held it in 7 quarters. The position peaked at $1.17M in Q1 2014. 540 funds tracked by Wall St. Rank hold DGX as of Q3 2015.

Wolf Group Capital Advisors reported no remaining Quest Diagnostics position as of Q3 2015 after selling out during the quarter.
Wolf Group Capital Advisors sold 3,347 Quest Diagnostics shares in Q3 2015, an estimated $243K.
Wolf Group Capital Advisors first reported a position in Quest Diagnostics in Q4 2013 and held it in 7 quarters.
Wolf Group Capital Advisors's Quest Diagnostics position peaked at $1.17M in Q1 2014.
540 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2015.

Based on Wolf Group Capital Advisors's 13F filing for Q3 2015, filed 6 Nov 2015.